Journal article

Blood and brain protein levels of ubiquitin-conjugating enzyme E2K (UBE2K) are elevated in individuals with schizophrenia

Hannah Meiklejohn, Md Shaki Mostaid, Sandra Luza, Serafino G Mancuso, Dali Kang, Sonny Atherton, Debora A Rothmond, Cynthia Shannon Weickert, Carlos M Opazo, Christos Pantelis, Ashley I Bush, Ian P Everall, Chad A Bousman

Journal of Psychiatric Research | PERGAMON-ELSEVIER SCIENCE LTD | Published : 2019

Grants

Awarded by National Health and Medical Research Council of Australia


Awarded by National Institute of Alcohol Abuse and Alcoholism


Awarded by National Health and Medical Research Council (Australia) Principal Research Fellowship


Awarded by National Health and Medical Research Council of Australia (NHMRC)


Awarded by NHMRC


Funding Acknowledgements

The authors acknowledge the financial support of the CRC for Mental Health. The Cooperative Research Centre (CRC) programme is an Australian Government Initiative. The authors also wish to acknowledge the CRC Scientific Advisory Committee, in addition to the contributions of study participants, clinicians at recruitment services, staff at the Murdoch Children's Research Institute, staff at the Australian Imaging, Biomarkers and Lifestyle Flagship Study of Aging, and research staff at the Melbourne Neuropsychiatry Centre, including coordinators Phassouliotis, C., Merritt, A., and research assistants, Burnside, A., Cross, H., Gale, S., and Tahtalian, S. Participants for this study were sourced, in part, through the Australian Schizophrenia Research Bank (ASRB), which is supported by the National Health and Medical Research Council of Australia (Enabling Grant N. 386500), the Pratt Foundation, Ramsay Health Care, the Viertel Charitable Foundation and the Schizophrenia Research Institute. Post-mortem tissues were received from the New South Wales Tissue Resource Center at the University of Sydney, which is supported by the National Health and Medical Research Council of Australia, Schizophrenia Research Institute, National Institute of Alcohol Abuse and Alcoholism (NIH (NIAAA) R24AA012725). CSW is funded by the NSW Ministry of Health, Office of Health and Medical Research. CSW is a recipient of a National Health and Medical Research Council (Australia) Principal Research Fellowship (1117079). CAB was supported by a National Health and Medical Research Council of Australia (NHMRC) Career Development Fellowship (1127700). CP was supported by NHMRC Senior Principal Research Fellowship (628386 & 1105825). AIB was supported by NHMRC Senior Principal Research Fellowship (1103703). None of the funding sources played any role in the study design; collection, analysis or interpretation of data; in the writing of the report; or in the decision to submit the paper for publication. We thank the Chief Investigators and ASRB Manager: Carr, V., Schall, U., Scott, R., Jablensky, A., Mowry, B., Michie, P., Catts, S., Henskens, F., Pantelis, C., Loughland, C. We acknowledge the help of Jason Bridge for ASRB database queries.